understand company trends and explore market opportunities. Collect and summarize the announcements of listed companies every day and present them to you at 18 o'clock every night!
![Understand company dynamics and explore market opportunities. Collect and summarize the announcements of listed companies every day and present them to you at 18 o'clock every night! [Add to increase and decrease holdings]: 1. [Hangxin Technology: Shareholder Bu Fansheng plans to - DayDayNews](https://cdn-dd.lujuba.top/img/loading.gif)
[Add to reduce holdings]:
1. [Hangxin Technology: Shareholder Bu Fansheng plans to reduce holdings by no more than 5.34% shares ]
November 17, Hangxin Technology announced that shareholder Bu Fansheng plans to reduce holdings by no more than 12.8143 million shares, that is, no more than 5.34% of the company's total share capital.
2. [Petti Shares: Directors and supervisors plan to reduce their holdings of the company by no more than 2% of the shares]
November 17, Petti Shares announced that Chen Zhenlu, the company's director, vice chairman and controlling shareholder, plans to reduce his holdings by no more than 5 million shares of the company, accounting for 1.99% of the company's current total share capital after excluding the number of shares in the repurchase account; Deng Zhaochun, chairman of the company's supervisory board, plans to reduce his holdings by no more than 37,000 shares of the company's current total share capital, accounting for 0.01% of the company's current total share capital after excluding the number of shares in the repurchase account.
[Contract winning bid]:
1, [ Ningbo Construction Engineering : Winning bid for the relocation and construction of the Traditional Chinese Medicine Hospital of Huazhou District, Weinan City PPP project ]
November 17, Ningbo Construction Engineering announced that the consortium of the company and its holding subsidiary municipal group won the bid for the relocation and construction of the Traditional Chinese Medicine Hospital of Huazhou District, Weinan City. The total investment of the project is 419 million yuan, the project cooperation period is 15 years, of which the construction period is 2 years and the operation and maintenance period is 13 years.
[Performance Forecast]:
1. [NetEase disclosed that Blizzard contributes to revenue and profit : the proportion is only low single digits]
November 17, NetEase disclosed in its third quarter financial report that the national service agent authorization of NetEase and Blizzard will expire in January 2023 and will not be renewed.
[Mergers and Acquisitions]:
1. [ Miaoke Landuo : Inner Mongolia Mengniu’s offer acquisition is completed, and the company’s stock will resume trading ]
November 17, Miaoke Landuo announced that during the period of the Inner Mongolia Mengniu , the total number of shareholder accounts that pre-accepted the offer is 305, and the total number of pre-accepted offers shares accounts for 5.25% of the company’s current shares; after the completion of this offer, Inner Mongolia Mengniu holds a total of 35.01% of the company’s shares.
2. [ Wingshi Technology : Anshi Semiconductor received an official notice from the UK, requiring at least divesting NWF86% stake in ]
November 17, Wingshi Technology announced that its subsidiary Anshi Semiconductor received a formal notice from the UK Department of Commerce, Energy and Industrial Strategy, requiring Anshi Semiconductor to divesting at least 86% of NWF8 according to the corresponding process within a certain period of time.
[Others]:
1. [Durui Medicine: Sodium Bicarbonate Linge Injection Obtains a Drug Registration Certificate]
November 17, Dorui Medicine announced that the company's wholly-owned subsidiary Hubei Dorui Pharmaceutical recently received the "Drug Registration Certificate" for Sodium Bicarbonate Linge Injection approved and issued by the State Food and Drug Administration.
2. [Northern funds today net purchase 1.409 billion Yiling Pharmaceutical net sales amount ranked first]
November 17, northern funds today net purchase 1.409 billion lb.
3. [Weichuang Electric: Proposed a fixed increase of no more than 1 billion yuan]
"Science and Innovation Board Daily" reported on the 17th that Weichuang Electric announced that it plans a fixed increase of no more than 1 billion yuan to be used for digital production base construction projects, Suzhou Technology R&D Center (Phase II) construction projects, information construction and intelligent warehousing projects, etc.
4. [Liyang Chip: Termination of issuance of A shares to specific objects]
"Science and Innovation Board Daily" reported on the 17th that in view of the changes in the domestic capital market environment, taking into account the actual situation of the company and the performance of the company's stock price market, the company decided to terminate the issuance of A shares to specific objects, and the "Dongcheng Liyang Chip Integrated Circuit Test Project" will be met through its own funds and other financing methods.
5. [ CITIC Securities : Issuing subprime corporate bonds not exceeding 20 billion yuan and corporate bonds not exceeding 60 billion yuan has been approved]
November 17, CITIC Securities announced that the company issued subprime corporate bonds to professional investors with a total face value of no more than 20 billion yuan has been approved for registration of China Securities Regulatory Commission; and the issuing corporate bonds to professional investors with a total face value of no more than 60 billion yuan has been approved for registration of China Securities Regulatory Commission;
6, [ Shanghai Yanpu : Received a fixed-point notice for new projects]
November 17, Shanghai Yanpu announced that the wholly-owned subsidiary Huangshan Yanpu recently received a "Fixed-point notice" from the Changzhou Branch of Dongfeng Lier Automobile Seat Co., Ltd. Huangshan Yanpu will supply a complete set of car seat skeleton assembly for the entire chair production of a model (DFL-EK) of the customer. At present, according to forecasts, the project is expected to generate 1.047 billion yuan in operating income in its life cycle.
7. [Traders Association accepts the registration and issuance of Xincheng Holdings for 15 billion yuan shelf]
November 17th. Today, the Traders Association accepts the registration and issuance of Xincheng Holdings for 15 billion yuan shelf, and is currently carrying out registration and evaluation in accordance with relevant self-discipline rules.
8. [ST Tiansheng: Furosemide injection passes generic drug consistency evaluation]
November 17, ST Tiansheng announced that the wholly-owned subsidiary Furosemide injection has passed the generic drug consistency evaluation.
9. [Feilong Co., Ltd.: Received a fixed-point letter from BAIC Off-road Vehicle Water Valve Assembly]
November 17, Feilong Co., Ltd. announced that the company recently received a "Feilong Co., Ltd.'s Off-road Vehicle Co., Ltd. (hereinafter referred to as "BAIC Off-road Vehicle").
10. [NetEase: Releases a new share repurchase plan, intending to repurchase the circulating American depositary shares and common shares in circulation no more than US$5 billion]
November 17th. NetEase announced today that its board of directors has approved a new share repurchase plan, that is, the total amount of US$5 billion of American depositary shares and common shares in circulation no more than US$5 billion in the open market within a period of no more than 36 months.
11, [ Dragon and Tiger List | Perfect World Today hit the daily limit 404 million yuan]
November 17, Perfect World hit the daily limit today, with trading volume 2.277 billion yuan, turnover rate 9.30%. After-hours Dragon and Tiger List data showed that Shenzhen Stock Connect special seats bought 259 million yuan and sold 164 million yuan, one institution bought 26.2037 million yuan, and four institution sold 404 million yuan.
12. [ Poly Development : Application for public issuance of corporate bonds not exceeding 9.9 billion yuan has been approved by the China Securities Regulatory Commission for registration]
November 17, Poly Development announced that the China Securities Regulatory Commission agreed to the company's registration application for public issuance of corporate bonds not exceeding 9.9 billion yuan to professional investors.
13. [ Zhongsheng Pharmaceutical hit the daily limit today. Shenzhen Stock Connect special seats bought 109 million yuan and sold 53.7308 million yuan]
November 17, Zhongsheng Pharmaceutical hit the daily limit today, with a turnover of 3.531 billion yuan and a turnover rate of 13.65%. After-hours Dragon and Tiger List data showed that Shenzhen Stock Connect special seats bought 109 million yuan and sold 53.7308 million yuan, and stock trading to support the family.
14. [France plans to build a solar module super factory]
"Science and Innovation Board Daily" reported on the 17th that Voltec Solar and the Ile-de-France Photovoltaic Research Institute (IPVF) are working together to build a solar module super factory in France.
15. [NetEase's third-quarter revenue was 24.4 billion yuan increased by 10.1% year-on-year compared with ]
November 17, NetEase's third-quarter revenue was 24.4 billion yuan, an increase of 10.1% year-on-year, and an estimated 24.36 billion yuan; gross profit in the third quarter was 13.7 billion yuan, an estimated 13.32 billion yuan.
16. [Dragon Tiger List | Yiling Pharmaceutical hit the daily limit today, and an institution bought 135 million yuan in net purchases]
November 17, Yiling Pharmaceutical hit the daily limit today, with a turnover of 8.576 billion yuan and a turnover rate of 15.13%. After-hours Dragon Tiger List data showed that Shenzhen Stock Connect special seats bought 252 million yuan and sold 580 million yuan, one institution bought 135 million yuan, and the other institution sold 134 million yuan.
17. [Semban Clothing: The controlling shareholder transfers a total of 8.0568 million shares to the two directors]
November 17, Semir Clothing announced that in order to support the company's healthy development and encourage and meet the willingness of the company's directors and senior executives to purchase and hold the company's shares for a long time, the company's controlling shareholder Qiu Guanghe transferred 5.3712 million shares of the company's shares to the company's director and general manager Xu Bo through bulk transactions, accounting for 0.1994% of the company's total share capital; and transferred 2.6856 million shares of the company's shares to the company's director and deputy general manager Shao Feichun, accounting for 0.0997% of the company's total share capital.
18. [Hong Kong Hang Seng Index closed down 1.15% and NetEase fell more than 9%]
November 17, Hong Kong Hang Seng Index closed down 1.15% and Hang Seng Technology Index fell 2.2%.
19. [ Tencent responds to whether to take over Blizzard copyright agent: no internal news yet]
November 17th. Blizzard will terminate the contract with NetEase. Some analysts believe that this part of the game copyright agent may be taken over by Tencent.
20, [ Fuchun Environmental Protection : Termination of the 2021 private placement of shares]
November 17, Fuchun Environmental Protection announced that due to the free transfer of state-owned equity of the company's controlling shareholder, the original controlling shareholder, Shuitian Group, has all transferred the company's shares to Nanchang Municipal Public Utilities Group Co., Ltd. (hereinafter referred to as "Municipal Group"). The company's controlling shareholder has been changed to a municipal group. Shuitian Group no longer holds the company's shares. The 2021 private placement plan has undergone major changes.
21. [Baolong Technology: Received a fixed-point notice for automotive sensor products]
November 17, Baolong Technology announced that it recently received a "Fixed-point notice" from a well-known European OEM factory, choosing the company as the product supplier for its new platform project brake wear sensors.
22. [ Hengrui Medicine : Pyrrolitinib maleate tablets are intended to be included in the priority review procedure]
November 17, Hengrui Medicine announced that the drug Pyrrolitinib maleate tablets are intended to be included in the public list of priority review varieties by the Drug Review Center of the State Food and Drug Administration. This product is combined with trastuzumab and docetaxel. It is suitable for the treatment of recurrent or metastatic breast cancer patients who are positive for epidermal growth factor receptor 2 (HER2) and have not received anti-HER2 treatment in the advanced stage.
